Timothy Daley
Stock Analyst at Wells Fargo
(2.03)
# 3,089
Out of 5,090 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $47.01 | -0.70% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $7.09 | +182.09% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $100.79 | -5.74% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $48.03 | +49.91% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $145.49 | -0.34% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,414.86 | -8.12% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $394.81 | -27.81% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $226.25 | +9.17% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $184.31 | +49.21% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $258.39 | +4.49% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.98 | +368.23% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $22.11 | +58.30% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $572.77 | -9.21% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.81 | +1,014.28% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $164.98 | +12.13% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.97 | +13.38% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $225.85 | -2.59% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $185.80 | +18.41% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $10.93 | +156.18% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $182.51 | -23.29% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $61.68 | +45.91% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $47.01
Upside: -0.70%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $7.09
Upside: +182.09%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $100.79
Upside: -5.74%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $48.03
Upside: +49.91%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $145.49
Upside: -0.34%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,414.86
Upside: -8.12%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $394.81
Upside: -27.81%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $226.25
Upside: +9.17%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $184.31
Upside: +49.21%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $258.39
Upside: +4.49%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.98
Upside: +368.23%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $22.11
Upside: +58.30%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $572.77
Upside: -9.21%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.81
Upside: +1,014.28%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $164.98
Upside: +12.13%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.97
Upside: +13.38%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $225.85
Upside: -2.59%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $185.80
Upside: +18.41%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $10.93
Upside: +156.18%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $182.51
Upside: -23.29%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $61.68
Upside: +45.91%